Prairiewood Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Prairiewood Capital's GILD Position: Q3 2025 in Review
Prairiewood Capital sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,227 shares — an estimated $358K sold.
Prairiewood Capital first reported a position in GILD in Q1 2021 and held it in 18 quarters. The position peaked at $1M in Q4 2021. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Prairiewood Capital reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Prairiewood Capital sold 3,227 Gilead Sciences shares in Q3 2025, an estimated $358K.
- Prairiewood Capital first reported a position in Gilead Sciences in Q1 2021 and held it in 18 quarters.
- Prairiewood Capital's Gilead Sciences position peaked at $1M in Q4 2021.
- 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Prairiewood Capital's 13F filing for Q3 2025, filed 14 Oct 2025.